Other

Changes in unrecognized tax benefits

Vertex Pharmaceuticals Changes in unrecognized tax benefits remained flat by 0.0% to 0.4% in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 87.6%, from 2.8% to 0.4%. Over 2 years (FY 2023 to FY 2025), Changes in unrecognized tax benefits shows a downward trend with a -35.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

A lower impact suggests stability in tax positions and reduced exposure to tax-related litigation.

Detailed definition

The percentage impact on the effective tax rate resulting from changes in unrecognized tax benefits. This metric isolate...

Peer comparison

Standard component of the effective tax rate reconciliation table.

Metric ID: other_effective_income_tax_rate_reconciliation_tax_conti_ef495c

Historical Data

3 years
 FY'23FY'24FY'25
Value3.4%11.3%1.4%
YoY Change+232.4%-87.6%
Range1.4%11.3%
CAGR-35.8%
Avg YoY Growth+72.4%
Median YoY Growth+72.4%

Changes in unrecognized tax benefits at Other Companies

Frequently Asked Questions

What is Vertex Pharmaceuticals's changes in unrecognized tax benefits?
Vertex Pharmaceuticals (VRTX) reported changes in unrecognized tax benefits of 0.4% in Q4 2025.
How has Vertex Pharmaceuticals's changes in unrecognized tax benefits changed year-over-year?
Vertex Pharmaceuticals's changes in unrecognized tax benefits decreased by 87.6% year-over-year, from 2.8% to 0.4%.
What is the long-term trend for Vertex Pharmaceuticals's changes in unrecognized tax benefits?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's changes in unrecognized tax benefits has grown at a -35.8% compound annual growth rate (CAGR), from 3.4% to 1.4%.
What does changes in unrecognized tax benefits mean?
The percentage impact on the effective tax rate caused by changes in reserves for uncertain tax positions.